GetTopicDetailResponse(id=61fc94116f5, topicName=過繼性, introduction=過繼性, content=null, image=null, comments=5, allHits=766, url=https://h5.medsci.cn/topic?id=94116, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=49282, tagList=[TagDto(tagId=49282, tagName=過繼性)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1813896, encodeId=acc81813896ed, content=<a href='/topic/show?id=61fc94116f5' target=_blank style='color:#2F92EE;'>#過繼性#</a>, objectTitle=2021美國癌癥研究學(xué)會年會速遞：改善實體瘤過繼性細胞療法的新策略, objectType=article, longId=209959, objectId=9e9920995971, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e9920995971, replyNumber=0, likeNumber=86, createdTime=2021-05-23, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e9920995971, moduleTitle=2021美國癌癥研究學(xué)會年會速遞：改善實體瘤過繼性細胞療法的新策略, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9e9920995971)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813895, encodeId=2e99181389550, content=<a href='/topic/show?id=61fc94116f5' target=_blank style='color:#2F92EE;'>#過繼性#</a>, objectTitle=Blood：Epo刺激T細胞可增強過繼性T細胞療法的抗腫瘤活性, objectType=article, longId=182245, objectId=ac0518224573, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac0518224573, replyNumber=0, likeNumber=99, createdTime=2020-10-09, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac0518224573, moduleTitle=Blood：Epo刺激T細胞可增強過繼性T細胞療法的抗腫瘤活性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ac0518224573)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813892, encodeId=f256181389206, content=<a href='/topic/show?id=61fc94116f5' target=_blank style='color:#2F92EE;'>#過繼性#</a>, objectTitle=Arthritis Rheumatol：系統(tǒng)性紅斑狼瘡的過繼性調(diào)節(jié)性T細胞療法, objectType=article, longId=150300, objectId=f9411503001f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9411503001f, replyNumber=0, likeNumber=112, createdTime=2018-11-08, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9411503001f, moduleTitle=Arthritis Rheumatol：系統(tǒng)性紅斑狼瘡的過繼性調(diào)節(jié)性T細胞療法, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f9411503001f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813893, encodeId=012a181389333, content=<a href='/topic/show?id=61fc94116f5' target=_blank style='color:#2F92EE;'>#過繼性#</a>, objectTitle=過繼性T細胞療法治療罕見的腦部感染, objectType=article, longId=151020, objectId=97741510203e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97741510203e, replyNumber=0, likeNumber=113, createdTime=2019-08-28, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97741510203e, moduleTitle=過繼性T細胞療法治療罕見的腦部感染, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=97741510203e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813894, encodeId=1f261813894f3, content=<a href='/topic/show?id=61fc94116f5' target=_blank style='color:#2F92EE;'>#過繼性#</a>, objectTitle=NEJM：首次！現(xiàn)貨過繼性T細胞療法在臨床試驗中成功挽救罕見致死性腦感染的癌癥患者, objectType=article, longId=151065, objectId=e8d21510656e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8d21510656e, replyNumber=0, likeNumber=95, createdTime=2019-01-17, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8d21510656e, moduleTitle=NEJM：首次！現(xiàn)貨過繼性T細胞療法在臨床試驗中成功挽救罕見致死性腦感染的癌癥患者, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e8d21510656e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
